Why Collegium Pharmaceutical Shares Are Tumbling 12.9% Today
After FDA commissioner Scott Gottlieb issued a statement suggesting an easier path to winning approval for generic opioids that are abuse deterrent, shares in Collegium Pharmaceutical's (NASDAQ: COLL) were sliding 12.9% at 3:45 p.m. EST Wednesday.
In an effort to boost the prescribing of abuse-deterrent opioid medicines for pain relief, Gottlieb's statement outlines changes that could increase competition and drive down the prices.
Image source: Getty Images.
Source: Fool.com